Immediate Impact
8 from Science/Nature 58 standout
Citing Papers
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
2023 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
Works of Jill Piens being referenced
Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jill Piens | 295 | 214 | 2 | 80 | 7 | 392 | |
| Lysiane Huber | 272 | 215 | 1 | 81 | 11 | 389 | |
| Kazuhiro Ohara | 338 | 137 | 84 | 6 | 398 | ||
| Karin Kemsley | 361 | 295 | 52 | 4 | 447 | ||
| Shivshankari Rajkumar | 297 | 222 | 1 | 118 | 7 | 442 | |
| Heike Seifert | 286 | 199 | 52 | 13 | 379 | ||
| Sara Davenport | 166 | 220 | 1 | 102 | 9 | 412 | |
| Hélène Malka-Mahieu | 382 | 135 | 31 | 10 | 449 | ||
| Flora Luo | 194 | 100 | 1 | 60 | 9 | 374 | |
| Esther Ong | 282 | 120 | 26 | 37 | 10 | 431 | |
| Timothy L. Helms | 282 | 273 | 41 | 5 | 440 |
All Works
Loading papers...